Search Results - Nathaniel R. Wilson
- Showing 1 - 6 results of 6
-
1
-
2
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy by Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R. Wilson, Sagar A. Naik, Vivek Subbiah, Matthew T. Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Published in Current Oncology (2024-06-01)Get full text
Article -
3
-
4
Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin: Single-Center Case Series by Mohammad Jad Moussa, Nathaniel R. Wilson, Anindita Ghosh, Meenakshi B. Bhattacharjee, Jonathan L. Curry, Woo Cheal Cho, Anisha B. Patel, Mouhammed Amir Habra, Sonali N. Thosani, Matthew T. Campbell, Arlene O. Siefker-Radtke, Omar Alhalabi, Nupur J. Kikani
Published in Annals of Internal Medicine: Clinical Cases (2025-05-01)Get full text
Article -
5
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma by Pavlos Msaouel, Eric Jonasch, Nizar M Tannir, Amishi Shah, Priya Rao, Omar Alhalabi, Matthew T Campbell, Tharakeswara K Bathala, Devaki Shilpa Surasi, Sangeeta Goswami, Elshad Hasanov, Khaled M Elsayes, Jaanki Khandelwal, Kanishka Sircar, Mohammad Jad Moussa, Kiran L Malikayil, Nathaniel R Wilson, Yiyun Lin, Pheroze Tamboli, Helen Ajufo, Andrew C Johns
Published in Journal for ImmunoTherapy of Cancer (2025-02-01)Get full text
Article -
6
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract by Mohammad Jad Moussa, Georges C. Tabet, Arlene O. Siefker‐Radtke, Lianchun Xiao, Nathaniel R. Wilson, Jianjun Gao, Christopher J. Logothetis, Petros Grivas, Byron Lee, Amishi Y. Shah, Pavlos Msaouel, Roger Li, Leticia Campos Clemente, Jianping Zhao, Nizar M. Tannir, Ashish M. Kamat, Donna E. Hansel, Charles C. Guo, Matthew T. Campbell, Omar Alhalabi
Published in Cancer Medicine (2025-01-01)Get full text
Article
